Effect of Empagliflozin on Cardiovascular and Kidney Outcomes in Patients with Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Diabetologie und Stoffwechsel2021cited by 7position: middledoi
Cardiovascular and Kidney Outcomes with Empagliflozin in Heart Failure
Diabetologie und Stoffwechsel2021cited by 5position: middledoi